{
  "id": "mhgap#management_c20d2fe6",
  "content": "– cocaine: Tardelli et al., 2020 (148); Nourredine et\nfrom drug use or improving retention to treatment.\nal., 2021 (149); Chan et al., 2020 (150); Buchholz\nand Saxon, 2019 (151); Chan et al., 2019 (152); y In adults with cocaine dependence, compared\nFluyau et al., 2021 (153); and with no treatment or TAU, there is some evidence\nfor effectiveness of: topiramate for increasing\n– methamphetamine: Tardelli et al., 2020 (148);\nabstinence in some studies (very low to\nSiefried et al., 2020 (154); Naji et al., 2022 (155);\nmoderate certainty); prescription amphetamines/\nNourredine et al., 2021 (149); Chan et al., 2020\ndexamphetamine for increasing abstinence (RR\n(150); Fluyau et al., 2021 (153); Chan et al., 2019\n= 2.44; 95% CI: 1.66 to 3.58; moderate certainty);\n(152); Lam et al., 2019 (156).\nbupropion for increasing abstinence (RR = 1.63; 95%\n– Note: The reviews by Tardelli et al. (148),\nCI: 1.03 to 2.59; very low certainty).\nChan et al. (150), Nourredine et al. (149) and\ny In adults with cocaine dependence, compared\nFluyau et al. (153) included both cocaine\nwith no treatment or TAU, there is limited evidence\nand methamphetamine.\nthat bupropion can potentially worsen treatment",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Management – cocaine: Tardelli et al., 2020 (148); Nourredine et\nfrom drug use or improving retention to treatment.\nal., 2021 (149); Chan et al., 2020 (150); Buchholz\nand Saxon, 2019 (151); Chan et al., 2019 (152); y In adults with cocaine dependence, compared\nFluyau et al., 2021 (153); and with no treatment or TAU, there is some evidence\nfor effectiveness of: topiramate for increasing\n– methamphetamine: Tardelli et al., 2020 (148);\nabstinence in some studies (very low to\nSiefried et al., 2020 (154); Naji et al., 2022 (155);\nmoderate certainty); prescription amphetamines/\nNourredine et al., 2021 (149); Chan et al., 2020\ndexamphetamine for increasing abstinence (RR\n(150); Fluyau et al., 2021 (153); Chan et al., 2019\n= 2.44; 95% CI: 1.66 to 3.58; moderate certainty);\n(152); Lam et al., 2019 (156).\nbupropion for increasing abstinence (RR = 1.63; 95%\n– Note: The reviews by Tardelli et al. (148),\nCI: 1.03 to 2.59; very low certainty).\nChan et al. (150), Nourredine et al. (149) and\ny In adults with cocaine dependence, compared\nFluyau et al. (153) included both cocaine\nwith no treatment or TAU, there is limited evidence\nand methamphetamine.\nthat bupropion can potentially worsen treatment – cocaine: tardelli et al., 2020 (148); nourredine et\nfrom drug use or improving retention to treatment. al., 2021 (149); chan et al., 2020 (150); buchholz\nand saxon, 2019 (151); chan et al., 2019 (152); y in adults with..."
}